DK108255C - Fremgangsmåde til fremstilling af alkylendiaminderivater eller syreadditionssalte eller kvaternære ammoniumsalte heraf. - Google Patents

Fremgangsmåde til fremstilling af alkylendiaminderivater eller syreadditionssalte eller kvaternære ammoniumsalte heraf.

Info

Publication number
DK108255C
DK108255C DK20163AA DK20163A DK108255C DK 108255 C DK108255 C DK 108255C DK 20163A A DK20163A A DK 20163AA DK 20163 A DK20163 A DK 20163A DK 108255 C DK108255 C DK 108255C
Authority
DK
Denmark
Prior art keywords
preparation
quaternary ammonium
acid addition
salts
addition salts
Prior art date
Application number
DK20163AA
Other languages
English (en)
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of DK108255C publication Critical patent/DK108255C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK20163AA 1962-01-18 1963-01-16 Fremgangsmåde til fremstilling af alkylendiaminderivater eller syreadditionssalte eller kvaternære ammoniumsalte heraf. DK108255C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL273727 1962-01-18

Publications (1)

Publication Number Publication Date
DK108255C true DK108255C (da) 1967-10-30

Family

ID=19753540

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20163AA DK108255C (da) 1962-01-18 1963-01-16 Fremgangsmåde til fremstilling af alkylendiaminderivater eller syreadditionssalte eller kvaternære ammoniumsalte heraf.

Country Status (6)

Country Link
BE (1) BE627240A (da)
BR (1) BR6346203D0 (da)
DE (1) DE1470121A1 (da)
DK (1) DK108255C (da)
FR (1) FR2481M (da)
GB (1) GB1031261A (da)

Also Published As

Publication number Publication date
BR6346203D0 (pt) 1973-07-19
FR2481M (fr) 1964-04-20
GB1031261A (en) 1966-06-02
BE627240A (nl) 1963-07-17
DE1470121A1 (de) 1969-05-29

Similar Documents

Publication Publication Date Title
DK109784C (da) Fremgangsmåde til fremstilling af naphthoxypropanolaminderivater eller syreadditionssalte deraf.
DK134160B (da) Fremgangsmåde til fremstilling af homopyrimidazolderivater eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK105476C (da) Fremgangsmåde til fremstilling af sekundære 2-aminomethylbenzodioxanderivater eller syreadditionssalte deraf.
DK115330B (da) Fremgangsmåde til fremstilling af pyridodioxepinderivater eller syreadditionssalte deraf.
DK117354B (da) Fremgangsmåde til fremstilling af disubstituerede aminoethoxyphenylaminer eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK104746C (da) Fremgangsmåde til fremstilling af 2-α-aminoalkanoylamido-benzophenon-forbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK103669C (da) Fremgangsmåde til fremstilling af phenthiazinderivater eller syreadditionssalte eller kvaternære ammoniumforbindelser heraf.
DK114977B (da) Fremgangsmåde til fremstilling af substituerede quinoliziner eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK108528C (da) Fremgangsmåde til fremstilling af diphenylpropylaminderivater eller syreadditionssalte deraf.
DK108255C (da) Fremgangsmåde til fremstilling af alkylendiaminderivater eller syreadditionssalte eller kvaternære ammoniumsalte heraf.
DK107291C (da) Fremgangsmåde til fremstilling af piperidinderivater eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK104982C (da) Fremgangsmåde til fremstilling af phentiazinderivater eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK104465C (da) Fremgangsmåde til fremstilling af 1-phenyl-2-alkylaminoalkanolderivater eller syreadditionssalte deraf.
DK104171C (da) Fremgangsmåde til fremstilling af morfantridinderivater eller syreadditionssalte heraf.
DK103077C (da) Fremgangsmåde til fremstilling af 4-hydroxyphenyl-4-carbalkoxy-piperidinderivater eller syreadditionssalte deraf.
DK104306C (da) Fremgangsmåde til fremstilling af 10-alkoxyyohimbaner eller syreadditionssalte eller kvartære ammoniumsalte deraf.
DK117959B (da) Fremgangsmåde til fremstilling af phenthiazinamidesterderivater eller syreadditionssalte eller kvaternære ammoniumderivater deraf.
DK119312B (da) Fremgangsmåde til fremstilling af 2-amino-4-alkoxy-s-trieziner eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK102464C (da) Fremgangsmåde til fremstilling af basisk substituerede polymethylentetrahydroquinoliner eller syreadditionssalte eller kvaternære ammoniumsalte heraf.
DK103562C (da) Fremgangsmåde til fremstilling af α-cyclopentyl-benzylaminer eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK100728C (da) Fremgangsmåde til fremstilling af 1-aza-thioxanthenforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK101690C (da) Fremgangsmåde til fremstilling af 1-aza-thioxanthenforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK101743C (da) Fremgangsmåde til fremstilling af 1-aza-thioxanthenforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK98628C (da) Fremgangsmåde til fremstilling af piperazinderivater eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK108790C (da) Fremgangsmåde til fremstilling af tetraethoxy-benzyl-tetrahydroisoquinolinderivater eller syreadditionssalte deraf.